Jailed 102 Months: Conti Operator Extorted 54 Firms
The Conti operator who threatened to leak stolen children's health records to extort payment just drew 102 months from DOJ's Criminal Division.
The Conti operator who threatened to leak stolen children's health records to extort payment just drew 102 months from DOJ's Criminal Division.
Madrigal's $1B bet on Arrowhead's ARO-PNPLA3 targets a PNPLA3 mutation affecting 30% of MASH patients that Rezdiffra doesn't cover.
Edge's autofill keeps plaintext passwords in process memory, creating a dump-and-steal path that sidesteps both Windows Hello and DPAPI.
A USB drop test went viral in 2026 because employees plugged in the drives within hours, exposing a gap in phishing-focused security programs.
A blood test that predicts who responds to Wegovy could hand payers the tool they need to narrow GLP-1 coverage, and Viridian cleared Phase 3 again.
Two chained CVEs in Ollama's Windows updater drop persistent RCE payloads on login, and three months after disclosure, there's still no patch.
The CFPB's April 2026 ECOA rule kills disparate impact for credit cards and auto loans, but leaves mortgage lenders still exposed under the FHA.
Virginia's class action bill looks like a consumer win, until you see where the $424 million goes. Mississippi would then stand alone.
A Telegram fraud ring called FEMITBOT is spoofing Apple, NVIDIA, and six other major brands to harvest deposits from fake crypto dashboards.
Mail-order mifepristone is back after the Supreme Court reversed an appeals stay, but the litigation that created the disruption is still running.
Amgen drops another $300M into its Puerto Rico biologics site, bringing Juncos to nearly $1B total and U.S. manufacturing pledges close to $2B.
GameStop offered $55.5B for eBay at $125 a share, a 46% premium, but CNBC's math found a $16 billion gap Ryan Cohen couldn't explain.
FDA ended nine adcomm-free months on April 30 with split votes on two AstraZeneca cancer drugs, but consultants warn it's a narrow restart.
ShinyHunters claims 275 million student and teacher records stolen from Instructure's Canvas platform, hitting nearly 9,000 schools worldwide.
Swiss biotech Windward Bio raised $165M to advance a China-derived drug into late-stage testing. What investors get from this bet is the real question.